Use of tamoxifen in pT1a-pT1b, pN0 breast cancer

European Journal of Surgical Oncology

Volumn 33, Issue 3, 2007, Pages 271-275

  Livi, L ^a   Saieva, C ^b   Paiar, F ^a   Simontacchi, G ^a   Galardi, A ^a   De Luca Cardillo, C ^a   Mangoni, M ^a   Paoletti, L ^a   Ponticelli, P ^c   Biti, G P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^c Arezzo Hospital   (Italy)

Author keywords

Breast cancer; Disease specific survival; Local recurrence; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HISTOLOGY; HUMAN; ITALY; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PHLEBITIS; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK REDUCTION; THROMBOEMBOLISM; TISSUE TYPES; UNIVARIATE ANALYSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAMOXIFEN; TREATMENT OUTCOME;

EID: 33947687826     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.05.021     Document Type: Article

References (23)

1. Goldhirsch A., Wood W.C., Gelber R.D., et al. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21 (2003) 3357-3365
2. Goldhirsch1 A., Glick J.H., Gelber R.D., Coates A.S., Thurlimann B., Senn H.-J., and Panel Members. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol (September 7, 2005)
3. Osborne C.K. Tamoxifen in the treatment of breast cancer. N Engl J Med 339 22 (1998 Nov 26) 1609-1618
4. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-468
5. Peto R., Pike M.C., and Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35 (1977) 1-39
6. Cox D.R. Regression models and life-tables. JR Stat Soc B 334 (1972) 187-202
7. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351 (1998) 1451-1467
8. Miller B.A., Feuer E.J., and Hankey B.F. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 43 (1993) 27-41
9. Goldhirsch A., Glick J.H., Gelbet R.D., et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 19 (2001) 3817-3827
10. Goldhirsch A., Wood W.C., Gelber R.D., et al. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21 (2003) 1-9
11. Lash T.L., Gurwitz J.H., and Silliman R.A. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer. J Am Geriatr Soc 53 (2005) 1889-1896
12. Nakhlis F., Lazarus L., and Hou N. Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma. J Am Coll Surg 201 (2005) 688-694
13. Fisher B., Costantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 90 (1998) 1371-1388
14. Fisher B., Dignam J., Tan-Chiu E., et al. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst 93 2 (2001 Jan 17) 112-120
15. Leitner S.P., Swern A.S., Weinberger D., Duncan L.J., and Hutter R.V. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a, b N0 M0). Cancer 76 (1995) 2266-2274
16. Lee A.K., Loda M., Mackarem G., et al. Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a, bN0M0): clinicopathologic features and outcome. Cancer 79 (1997) 761-771
17. Stierer M., Rosen H.R., Weber R., Marczell A., Kornek G.V., and Czerwenka E. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynecol Obstet 175 (1992) 151-160
18. Touboul E., Buffat L., Belkacemi Y., et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43 1 (1999) 25-38
19. Fisher B., Anderson S., Tan-Chiu E., et al. Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor - negative breast cancer: findings from national surgical adjuvant breast and bowel project B-23. J Clin Oncol 19 (2001) 931-942
20. Sandra M. Swain tamoxifen for patients with estrogen receptor - negative breast cancer. J Clin Oncol 19 18s (2001) 93s-97s [September 15 Supplement]
21. Arnesson L.G., Smeds S., and Fagerberg G. Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening. Eur J Surg 160 (1994) 271-276
22. Strasser-Weippl K., and Goss P.E. Advances in adjuvant hormonal therapy for postmenopausal women. J Clin Oncol 23 8 (2005 Mar 10) 1751-1759
23. Cuzick J., Powles T., Veronesi U., et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 361 (2003) 296-300